MedPath

瑞迪博士(北京)药业有限公司

Ownership
-
Established
2020-08-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20249281
Approval Date
Nov 5, 2024
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20249280
Approval Date
Nov 5, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.